ReproCyc PRRS EU inj. susp. (lyoph.) i.m. vial

País: Bélgica

Idioma: inglés

Fuente: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredientes activos:

Porcine Reproductive and Respiratory Syndrome Virus (Live, Attenuated)

Disponible desde:

Boehringer Ingelheim Vetmedica GmbH

Código ATC:

QI09AD03

Designación común internacional (DCI):

Porcine Respiratory and Reproductive Syndrome Virus (PRRSV), Live, Attenuated

formulario farmacéutico:

Lyophilisate and solvent for suspension for injection

Composición:

Porcine Respiratory and Reproductive Syndrome Virus (PRRSV), Live, Attenuated

Vía de administración:

Intramuscular use

Grupo terapéutico:

pig

Área terapéutica:

Porcine Reproductive and Respiratory Syndrome (PRRS) Virus

Resumen del producto:

CTI code: 474880-06 - Pack size: 25 x 100 doses (200 (200) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-04 - Pack size: 25 x 10 doses (20 (20) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-05 - Pack size: 25 x 50 doses (100 (100) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-02 - Pack size: 12 x 50 doses (100 (100) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-03 - Pack size: 12 x 100 doses (200 (200) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 474880-01 - Pack size: 12 x 10 doses (20 (20) - Commercialisation status: NO - Delivery mode: Medical prescription

Estado de Autorización:

Commercialised: No

Fecha de autorización:

2015-06-16